Actively Recruiting
Evaluating Nebulized Amikacin Plus Standard Care Versus Standard Care Alone for Gram-negative Pneumonia in Patients Receiving Veno-arterial ECMO Support
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-08-13
26
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Pneumonia is a common and serious infection in patients receiving Veno-arterial Extracorporeal Membrane Oxygenation ECMO-VA, with a high rate of treatment failure despite tailored antibiotic therapy. This study explores whether nebulized amikacin can improve bacterial clearance and reduce treatment failure or recurrence of gram-negative bacilli pneumonia during mechanical ventilation in these patients. Participants in this randomized trial will either receive inhaled amikacin by nebulization at a dose of 25 mgkg once daily for 5 days alongside standard care, or standard care alone without nebulization. The treatment begins within 6 hours of randomization. The study focuses on comparing the effectiveness of nebulized amikacin plus standard care versus standard care alone in this specific patient group. During the study, researchers will monitor bacterial eradication rates by Day 5 as the primary outcome, along with clinical cure, pneumonia persistence, pulmonary infection scores, aeration scores, adverse events, and pharmacokinetic analyses of amikacin and piperacillin-tazobactam. Patients must be on mechanical ventilation and have confirmed gram-negative ventilator-associated pneumonia. Safety and treatment responses will be closely assessed during the 5-day treatment period.
CONDITIONS
Brief Title
" Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "
Research Team
P
Pauline DUREAU, MD, PhD
A
Alexis PEREZ CALOC, Clinical project manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here